Cost-containment | Cost-effectiveness | |||
---|---|---|---|---|
I agree with limiting reimbursement for expensive drugs and procedures if that would help expand access to basic healthcare for those currently lacking such care. | I object to using cost-effectiveness data to determine which treatments will be offered to patients. | |||
Unadjusted OR | Adjusted OR | Unadjusted OR | Adjusted OR | |
(95% CI) | (95% CI) | (95% CI) | (95% CI) | |
Harm | 1.2 (1.0–1.4)* | 1.2 (1.0–1.5)* | 1.2 (1.0–1.4)* | 1.2 (1.0–1.4) |
Fairness | 1.7 (1.4–2.0)* | 1.7 (1.4–2.1)* | 0.9 (0.8–1.1) | 0.9 (0.7–1.0) |
Ingroup | 1.0 (0.8–1.1) | 1.0 (0.8–1.2) | 1.0 (0.9–1.2) | 1.0 (0.9–1.2) |
Authority | 0.9 (0.8–1.0) | 0.9 (0.8–1.1) | 1.0 (0.9–1.2) | 1.0 (0.9–1.2) |
Purity | 0.9 (0.8–1.0) | 1.0 (0.9–1.1) | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) |